Patient-centered biomarker research and development hub kicks-off

Mainz, Germany, March 8, 2013 – Clinicians, scientists and technologists in the Rhine-Main area have come together to make biomarker research and use an integral part of the treatment routine for individual cancer patients. The effort will combine the expertise of regional medical centers, research institutes and technology companies.

The program, an integral project of the Cluster for Individualized ImmuneIntervention, is supported by the German Ministry for Education and Research. A total of 5.6 Mio Euro will enable the development and implementation of a modular platform combining biobanking, diversified bioanalytics, bioinformatics, high performance computing, and diagnostics.

A total of nine expert organizations are directly involved in the project. TRON, the project leader, will coordinate the integration of infrastructures to harmonize, standardize and optimize the clinical implementation of cutting-edge technologies.

Project partners:

JGU Mainz    

     Frauenhofer ITWM 

Krankenhaus Nordwest      

medesso gmbh

UCT Frankfurt    

  Universitätsmedizin Mainz